The Iowa DOT wanted to reopen the University Avenue on-ramp to I-80/35. Traffic backups on the mixmaster ended that plan.
Crews will reduce southbound I-5 to two lanes each night starting as early as 11 p.m., with all lanes reopening by 4:30 a.m.
Did you encounter traffic backups at the southwest mixmaster this week? Here's why the University Avenue on-ramp is closed to ...
The collaboration integrates Coinme’s stablecoin and crypto payments platform, which provides partners with U.S.-market rails for liquidity, settlement, custody, and on-ramp transaction fulfillment — ...
A traffic collision between two vehicles at 9:16 a.m. Saturday, on Interstate I-880 Southbound, has blocked the Montague Expressway ramp. California Highway Patrol reported two motorists collided at ...
CHARLESTON, W.Va. (WSAZ) - A busy on-ramp to I-77 is shut down after a single vehicle crash. According to a Metro 911 supervisor, the vehicle went off of the interstate and down the roadway and is now ...
Improvement work on the Parkway East will impact traffic in Allegheny County, starting Monday and lasting into the spring. PennDOT crews will implement single-lane closures in each direction of I-376 ...
Verastem Oncology Provides Update on RAMP 203 Phase 1/2 Clinical Trial for Advanced KRAS G12C Mutant Non-Small Cell Lung Cancer Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed ...
BOSTON--(BUSINESS WIRE)-- Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with RAS/MAPK pathway-driven cancers, today announced that ...
The last time I wrote about Verastem, Inc. (VSTM) it was in a Seeking Alpha article entitled "Verastem: RAMP-203 Study Could Be Next Big Win For Avutometinib Combination." With respect to this article ...
GREENSBORO, N.C. (WGHP) — A pedestrian was hit and killed in an early morning crash in Greensboro. According to the Greensboro Police Department, they responded to a crash at 3:22 a.m. in the area of ...
RAMP 203 is a Phase 1/2 clinical trial being conducted in collaboration with Amgen evaluating avutometinib, an oral RAF/MEK clamp, and LUMAKRAS™ (sotorasib) in a “doublet combination” and also with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results